Recruiting Multiple Myeloma Studies in Longmont
About Multiple Myeloma Clinical Trials in Longmont
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 1 multiple myeloma clinical trials recruiting participants in Longmont, COLORADO. These studies are seeking a combined 80 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Longmont — FAQ
Are there multiple myeloma clinical trials in Longmont?
Yes, there are 1 multiple myeloma clinical trials currently recruiting in Longmont, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Longmont?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Longmont research site will contact you about next steps.
Are clinical trials in Longmont free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Longmont studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 1 active trials in Longmont are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated March 2, 2026 from ClinicalTrials.gov